In 2024, the trade exchange (includes international purchases and sales) of Prepared Preserved Meat or Offal Bovines (Exc Sausages and Similar Products .; Preparations Homogenised for Infant or for Uses Dietary Upgraded for Retail in Containers of <= 250 G.; Preparations of Liver Extracts and Gravies) was US$22.7M.
In 2024, the states with the most international sales in Prepared Preserved Meat or Offal Bovines (Exc Sausages and Similar Products .; Preparations Homogenised for Infant or for Uses Dietary Upgraded for Retail in Containers of <= 250 G.; Preparations of Liver Extracts and Gravies) were Nuevo León (US$2.22M) and Coahuila de Zaragoza (US$732k).
The states with the most international purchases in 2024 were Ciudad de México (US$8.55M), Estado de México (US$3.7M), Nuevo León (US$1.06M), Chihuahua (US$369k), and Baja California (US$177k).
In 2024, the main commercial destinations of Prepared Preserved Meat or Offal Bovines (Exc Sausages and Similar Products .; Preparations Homogenised for Infant or for Uses Dietary Upgraded for Retail in Containers of <= 250 G.; Preparations of Liver Extracts and Gravies) were United States (US$2.96M).
The main commercial origins of Prepared Preserved Meat or Offal Bovines (Exc Sausages and Similar Products .; Preparations Homogenised for Infant or for Uses Dietary Upgraded for Retail in Containers of <= 250 G.; Preparations of Liver Extracts and Gravies) in 2024 were United States (US$7.48M), Nicaragua (US$3.09M), Panama (US$1.98M), Brazil (US$734k), and Chile (US$281k).
In the global context, the main exporting countries of Prepared Preserved Meat or Offal Bovines (Exc Sausages and Similar Products .; Preparations Homogenised for Infant or for Uses Dietary Upgraded for Retail in Containers of <= 250 G.; Preparations of Liver Extracts and Gravies) in 2022 were Brazil (US$777M), United States (US$311M), and Germany (US$217M). In the same year, the main importing countries of Prepared Preserved Meat or Offal Bovines (Exc Sausages and Similar Products .; Preparations Homogenised for Infant or for Uses Dietary Upgraded for Retail in Containers of <= 250 G.; Preparations of Liver Extracts and Gravies) were United States (US$702M), United Kingdom (US$322M), and Canada (US$208M).